Literature DB >> 9108791

Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians.

P M Mannucci1, D Mari, G Merati, F Peyvandi, L Tagliabue, E Sacchi, E Taioli, P Sansoni, S Bertolini, C Franceschi.   

Abstract

Gene polymorphisms associated with the plasma levels of fibrinogen, factor VII, and plasminogen activator inhibitor 1 (PAI-1)-hemostasis proteins that help to predict the risk of atherothrombotic disease-were compared in 124 healthy individuals > or = 100 years old and 130 young, healthy individuals to identify genetic influences on extreme longevity. We investigated the restriction fragment length polymorphism G/A-455 located in the promoter of the beta-fibrinogen gene, the guanine insertion/deletion polymorphism 4G/5G in the promoter of the PAI-1 gene, and the R353Q substitution polymorphism in exon 8 of the factor VII gene. Alleles and genotypes associated with elevated plasma levels of fibrinogen and factor VII were found with similar frequencies in centenarians and in the comparison group. However, in centenarians there was a significantly higher frequency of the 4G allele and of the homozygous 4G4G genotype associated with high PAI-1 levels. Since high PAI-1 is considered a predictor of recurrent myocardial infarction in young men, it is intriguing that the corresponding genetic marker is more frequent in centenarians who have escaped major age-related atherothrombotic disease and reached the extreme limits of human life. Homozygosity for the 4G allele, despite its association with impaired fibrinolysis, is compatible with successful aging.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108791     DOI: 10.1161/01.atv.17.4.755

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  9 in total

Review 1.  Genetic epidemiology in aging research.

Authors:  M Daniele Fallin; Amy Matteini
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-23       Impact factor: 6.053

Review 2.  Causes, effects, and constraints in the genetics of human longevity.

Authors:  F Schächter
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

Review 3.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

Authors:  Matteo Cesari; Marco Pahor; Raffaele Antonelli Incalzi
Journal:  Cardiovasc Ther       Date:  2010-07-07       Impact factor: 3.023

4.  Angiotensin-Converting Enzyme Gene Polymorphism and Plasminogen Activator Inhibitor 1 Levels in Subjects with Cerebral Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-07       Impact factor: 2.300

5.  Plasma proteome profiling of healthy individuals across the life span in a Sicilian cohort with long-lived individuals.

Authors:  Valentina Siino; Ashfaq Ali; Giulia Accardi; Anna Aiello; Mattia E Ligotti; Sergio Mosquim Junior; Giuseppina Candore; Calogero Caruso; Fredrik Levander; Sonya Vasto
Journal:  Aging Cell       Date:  2022-08-06       Impact factor: 11.005

6.  Hemostasis and ageing.

Authors:  Daniela Mari; Giulia Ogliari; Davide Castaldi; Giovanni Vitale; Elisa Mariadele Bollini; Domenico Lio
Journal:  Immun Ageing       Date:  2008-10-23       Impact factor: 6.400

Review 7.  Inflammaging as a prodrome to Alzheimer's disease.

Authors:  Brian Giunta; Francisco Fernandez; William V Nikolic; Demian Obregon; Elona Rrapo; Terrence Town; Jun Tan
Journal:  J Neuroinflammation       Date:  2008-11-11       Impact factor: 8.322

Review 8.  Puzzling role of genetic risk factors in human longevity: "risk alleles" as pro-longevity variants.

Authors:  Svetlana Ukraintseva; Anatoliy Yashin; Konstantin Arbeev; Alexander Kulminski; Igor Akushevich; Deqing Wu; Gaurang Joshi; Kenneth C Land; Eric Stallard
Journal:  Biogerontology       Date:  2015-08-26       Impact factor: 4.277

9.  Hepatocyte gene expression and DNA methylation as ancestry-dependent mechanisms in African Americans.

Authors:  C S Park; T De; Y Xu; Y Zhong; E Smithberger; C Alarcon; E R Gamazon; M A Perera
Journal:  NPJ Genom Med       Date:  2019-11-25       Impact factor: 8.617

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.